BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/26/2021 9:58:01 AM | Browse: 288 | Download: 624
 |
Received |
|
2021-01-20 15:44 |
|
Peer-Review Started |
|
2021-01-20 15:46 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-02-12 11:20 |
|
Revised |
|
2021-02-26 14:17 |
|
Second Decision |
|
2021-04-23 11:29 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-04-23 12:06 |
|
Articles in Press |
|
2021-04-23 12:06 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-04-28 22:02 |
|
Typeset the Manuscript |
|
2021-05-20 13:08 |
|
Publish the Manuscript Online |
|
2021-05-26 09:58 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Systematic Reviews |
| Article Title |
COVID-19 in gastroenterology and hepatology: Lessons learned and questions to be answered
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Shao Liu, Mi-Mi Tang, Jie Du, Zhi-Cheng Gong and Shu-Sen Sun |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Key Research and Development Program of Hunan Province |
2020SK3022 |
|
| Corresponding Author |
Shu-Sen Sun, PharmD, PhD, Chief Pharmacist, Department of Pharmacy Practice, College of Pharmacy and Health Sciences, Western New England University, 1215 Wilbraham Road, Springfield, MA 01119, United States. shusen.sun@wne.edu |
| Key Words |
COVID-19; SARS-CoV-2; Gastroenterology; Hepatology; Endoscopy; Inflammatory bowel disease |
| Core Tip |
Recent studies suggest that multiorgan, including gastrointestinal (GI) tract and liver damage, involvement in patients that are infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In detail, digestive symptoms and liver injury are not uncommon in patients with coronavirus disease-2019, and varies in different individuals. The most common GI symptoms reported are diarrhea, nausea, vomiting, and abdominal discomfort. Liver chemistry abnormalities are also common, including elevation of aspartate transferase, alanine transferase, and total bilirubin. It is postulated to be mainly connected to the binding of SARS-CoV-2 virus and its receptors angiotensin converting enzyme-2 which located on several different human cells. |
| Publish Date |
2021-05-26 09:58 |
| Citation |
Liu S, Tang MM, Du J, Gong ZC, Sun SS. COVID-19 in gastroenterology and hepatology: Lessons learned and questions to be answered. World J Clin Cases 2021; 9(17): 4199-4209 |
| URL |
https://www.wjgnet.com/2307-8960/full/v9/i17/4199.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v9.i17.4199 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
